|A gene-expression signature as a predictor of survival in breast cancer|
MJ Van De Vijver, YD He, LJ Van't Veer, H Dai, AAM Hart, DW Voskuil, ...
New England Journal of Medicine 347 (25), 1999-2009, 2002
|70-gene signature as an aid to treatment decisions in early-stage breast cancer|
F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ...
New England Journal of Medicine 375 (8), 717-729, 2016
|Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer|
M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ...
Journal of the National Cancer Institute 98 (17), 1183-1192, 2006
|Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer|
R Salazar, P Roepman, G Capella, V Moreno, I Simon, C Dreezen, ...
J clin oncol 29 (1), 17-24, 2011
|Converting a breast cancer microarray signature into a high-throughput diagnostic test|
AM Glas, A Floore, LJMJ Delahaye, AT Witteveen, RCF Pover, N Bakx, ...
BMC genomics 7 (1), 1-10, 2006
|Gene expression profiles of primary breast tumors maintained in distant metastases|
B Weigelt, AM Glas, LFA Wessels, AT Witteveen, JL Peterse, LJ van't Veer
Proceedings of the National Academy of Sciences 100 (26), 15901-15905, 2003
|Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer|
B Weigelt, Z Hu, X He, C Livasy, LA Carey, MG Ewend, AM Glas, ...
Cancer research 65 (20), 9155-9158, 2005
|The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study|
S Mook, MK Schmidt, G Viale, G Pruneri, I Eekhout, A Floore, AM Glas, ...
Breast cancer research and treatment 116, 295-302, 2009
|Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)|
JM Bueno-de-Mesquita, WH van Harten, VP Retel, LJ van't Veer, ...
The lancet oncology 8 (12), 1079-1087, 2007
|The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer|
ME Straver, AM Glas, J Hannemann, J Wesseling, MJ van de Vijver, ...
Breast cancer research and treatment 119, 551-558, 2010
|Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment|
AM Glas, MJ Kersten, LJMJ Delahaye, AT Witteveen, RE Kibbelaar, ...
Blood 105 (1), 301-307, 2005
|Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.|
AM Glas, L Knoops, L Delahaye, MJ Kersten, RE Kibbelaar, LA Wessels, ...
|Validation of 70-gene prognosis signature in node-negative breast cancer|
JM Bueno-de-Mesquita, SC Linn, R Keijzer, J Wesseling, DSA Nuyten, ...
Breast cancer research and treatment 117, 483-495, 2009
|Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary|
HM Horlings, RK van Laar, JM Kerst, HH Helgason, J Wesseling, ...
Journal of Clinical Oncology 26 (27), 4435-4441, 2008
|The 70-gene prognosis signature predicts early metastasis in breast cancer patients between 55 and 70 years of age|
S Mook, MK Schmidt, B Weigelt, B Kreike, I Eekhout, MJ Van de Vijver, ...
Annals of oncology 21 (4), 717-722, 2010
|Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort|
BS Wittner, DC Sgroi, PD Ryan, TJ Bruinsma, AM Glas, A Male, S Dahiya, ...
Clinical Cancer Research 14 (10), 2988-2993, 2008
|A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response|
O Krijgsman, P Roepman, W Zwart, JS Carroll, S Tian, FA de Snoo, ...
Breast cancer research and treatment 133, 37-47, 2012
|Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer|
M Maak, I Simon, U Nitsche, P Roepman, M Snel, AM Glas, T Schuster, ...
Annals of surgery 257 (6), 1053-1058, 2013
|Biological functions of the genes in the mammaprint breast cancer profile reflect the hallmarks of cancer|
S Tian, P Roepman, LJ Van't Veer, R Bernards, F De Snoo, AM Glas
Biomarker insights 5, BMI. S6184, 2010
|70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age|
M Piccart, LJ van't Veer, C Poncet, JMNL Cardozo, S Delaloge, JY Pierga, ...
The Lancet Oncology 22 (4), 476-488, 2021